- ►annals.org [PDF] JM Weiler, JR Bloomfield, GG Woodworth, AR … - Annals of Internal Medicine, 2000 - Am Coll Physicians John M. Weiler, MD; John R. Bloomfield, PhD; George G. Woodworth, PhD; Angela R.
Grant, BS; Teresa A. Layton, BSN; Timothy L. Brown, MS; David R. McKenzie, MS;
Thomas W. Baker, MS; and Ginger S. Watson, PhD ... Background: Sedating ... Cited by 167 - Related articles - BL Direct - All 9 versions
A Vermeeren, JF O'Hanlon - Journal of Allergy and Clinical Immunology, 1998 - Elsevier Fexofenadine was recently approved by the Food and Drug Administration in the
dosage of 60 mg twice daily for the indication of seasonal allergic rhinitis.
Its structure is identical to terfenadine's active metabolite, except that ... Cited by 75 - Related articles - BL Direct - All 5 versions
GG Kay, B Berman, SH Mockoviak, CE Morris, … - Archives of Internal Medicine, 1997 - archinte.highwire.org Background: The classic, first-generation histamine1\x=req-\ receptor
antagonists used to treat allergic disorders fre- quently cause sedation. In
contrast, sedation is reduced or absent after administration of recommended ... Cited by 74 - Related articles - BL Direct - All 6 versions
TM Gilmore, BH Alexander, BA Mueller, FP … - American journal of industrial medicine, 1996 - interscience.wiley.com Recent medication use of 3,394 members of the Group Health Cooperative of Puget
Sound (GHC) diagnosed with an incident work-related injury was compared to that
of two controls selected from the GHC membership and matched on age, ... Cited by 75 - Related articles - BL Direct - All 4 versions
E Vuurman, LMA Van Veggel, MMC Uiterwijk, … - Annals of allergy, 1993 - cat.inist.fr Seasonal allergic rhinitis and antihistamine effects on children's learning.
EFPM VUURMAN, LMA VAN VEGGEL, MMC UITERWIJK, D LEUTNER ... Cited by 237 - Related articles - BL Direct - All 2 versions
JF O'Hanlon, JG Ramaekers - Allergy, 1995 - interscience.wiley.com The review summarizes the major results of eight double-blind,
placebo-controlled, volunteer studies undertaken by three independent
institutions for showing the effects on actual driving performance of ... Cited by 84 - Related articles - BL Direct - All 4 versions
AN Nicholson, BM Stone, C Turner, SL Mills - Aviation, space, and environmental medicine, 2000 - ncbi.nlm.nih.gov INTRODUCTION: The aim of this study was to establish whether fexofenadine
hydrochloride, an antihistamine, modulates daytime sleepiness or performance.
METHODS: The effects of fexofenadine (120, 180, and 240 mg) on digit symbol ... Cited by 39 - Related articles - BL Direct - All 10 versions
I Hindmarch, Z Shamsi, N Stanley, DB … - British journal of clinical pharmacology, 1999 - pubmedcentral.nih.gov Twenty-four healthy volunteers received fexofenadine 80 mg, 120 mg and 180 mg,
loratadine 10 mg, promethazine 30 mg (as a positive internal control) and
placebo in a six-way crossover, double-blind study. Following each dose, ... Cited by 56 - Related articles - BL Direct - All 5 versions
WD Finkle, JL Adams, S Greenland, KL … - Annals of Allergy, Asthma and Immunology, 2002 - ingentaconnect.com William D. Finkle, MS, PhD*; John L. Adams, PhD†; Sander Greenland, MS,
PhD‡; and Kenneth L. Melmon§ † ... Background: Diphenhydramine may be
associated with excess risk of injury relative to nonsedating H Cited by 30 - Related articles - BL Direct - All 11 versions
I Hindmarch, Z Shamsi, S Kimber… - Clinical & Experimental Allergy, 2002 - interscience.wiley.com BackgroundAs regards central nervous system (CNS) effects there are three types
of antihistamines. Those that cross the blood‐brain barrier and cause
widespread impairment of cognitive and psychomotor function; those that ... Cited by 58 - Related articles - BL Direct - All 5 versions
